-
1
-
-
0034735842
-
Infliximab and methotrexate in the treatment of rheumatoid arthritis
-
Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
-
Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594-1602
-
(2000)
N Engl J Med
, vol.343
, pp. 1594-1602
-
-
Lipsky, P.E.1
van der Heijde, D.M.2
St Clair, E.W.3
-
2
-
-
10744223002
-
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomized controlled trial
-
Klareskog L, van der Heijde D, de Jager JP et al (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomized controlled trial. Lancet 363:675-681
-
(2004)
Lancet
, vol.363
, pp. 675-681
-
-
Klareskog, L.1
van der Heijde, D.2
de Jager, J.P.3
-
3
-
-
0036167283
-
Experience with etanercept in an academic medical center: Are infection rates increased
-
Phillips K, Husni ME, Karlson EW, Coblyn JS (2002) Experience with etanercept in an academic medical center: Are infection rates increased. Arthritis Rheum 47:17-21
-
(2002)
Arthritis Rheum
, vol.47
, pp. 17-21
-
-
Phillips, K.1
Husni, M.E.2
Karlson, E.W.3
Coblyn, J.S.4
-
4
-
-
16644398295
-
Serious infections associated with anticytokine therapies in the rheumatic diseases
-
Giles JT, Bathon JM (2004) Serious infections associated with anticytokine therapies in the rheumatic diseases. J Intensive Care Med 19:320-334
-
(2004)
J Intensive Care Med
, vol.19
, pp. 320-334
-
-
Giles, J.T.1
Bathon, J.M.2
-
5
-
-
24144456554
-
Infections associated with tumor necrosis factor-alpha antagonists
-
Rychly DJ, DiPiro JT (2005) Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 25:1181-1192
-
(2005)
Pharmacotherapy
, vol.25
, pp. 1181-1192
-
-
Rychly, D.J.1
DiPiro, J.T.2
-
6
-
-
38149096918
-
Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases
-
Tamaki K, Kogata Y, Sugiyama D et al (2008) Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 35:114-119
-
(2008)
J Rheumatol
, vol.35
, pp. 114-119
-
-
Tamaki, K.1
Kogata, Y.2
Sugiyama, D.3
-
7
-
-
0034465540
-
Postoperative spinal wound infection: A review of 2,391 consecutive index procedures
-
Weinstein MA, McCabe JP, Cammisa FP Jr. (2000) Postoperative spinal wound infection: A review of 2,391 consecutive index procedures. J Spinal Disord 13:422-426
-
(2000)
J Spinal Disord
, vol.13
, pp. 422-426
-
-
Weinstein, M.A.1
McCabe, J.P.2
Cammisa Jr., F.P.3
-
8
-
-
0027533715
-
Late infection of spinal instrumentation by hematogenous seeding
-
Heggeness MH, Esses SI, Errico T, Yuan HA (1993) Late infection of spinal instrumentation by hematogenous seeding. Spine 18:492-496
-
(1993)
Spine
, vol.18
, pp. 492-496
-
-
Heggeness, M.H.1
Esses, S.I.2
Errico, T.3
Yuan, H.A.4
-
10
-
-
0026801018
-
Postoperative wound infections complicating adult spine surgery
-
Stambough JL, Beringer D (1992) Postoperative wound infections complicating adult spine surgery. J Spinal Disord 5:277-285
-
(1992)
J Spinal Disord
, vol.5
, pp. 277-285
-
-
Stambough, J.L.1
Beringer, D.2
-
11
-
-
33645904180
-
Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis
-
Giles JT, Bartlett SJ, Gelber AC et al (2006) Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 55:333-337
-
(2006)
Arthritis Rheum
, vol.55
, pp. 333-337
-
-
Giles, J.T.1
Bartlett, S.J.2
Gelber, A.C.3
-
12
-
-
34447625751
-
Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers
-
Ruyssen-Witrand A, Gossec L, Salliot C et al (2007) Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol 25:430-436
-
(2007)
Clin Exp Rheumatol
, vol.25
, pp. 430-436
-
-
Ruyssen-Witrand, A.1
Gossec, L.2
Salliot, C.3
-
13
-
-
37449017748
-
Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
-
Koike R, Takeuchi T, Eguchi K, Miyasaka N (2007) Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol 17:451-458
-
(2007)
Mod Rheumatol
, vol.17
, pp. 451-458
-
-
Koike, R.1
Takeuchi, T.2
Eguchi, K.3
Miyasaka, N.4
-
14
-
-
14044260093
-
Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
-
Ledingham J, Deighton C (2005) Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 44:157-163
-
(2005)
Rheumatology (Oxford)
, vol.44
, pp. 157-163
-
-
Ledingham, J.1
Deighton, C.2
|